je.st
news
Tag: early
EkkoSense partners with SSEN to conduct early warning sensor trials
2016-10-26 01:00:00| Power Technology
UK-based remote sensor monitoring company EkkoSense has partnered with electricity network provider Scottish and Southern Electricity Networks (SSEN) to conduct trials on an early warning sensor solution.
Tags: early
partners
warning
conduct
Early Power secures approval from Ghanaian Parliament
2016-10-26 01:00:00| Power Technology
The Early Power consortium has secured parliamentary approval from the Government of Ghana and subsequently signed a 20-year power purchase agreement (PPA).
Tags: power
early
approval
parliament
Michigan Residents to Receive Early Trash Pickup on Halloween to Keep Trick-or-Treaters Safe
2016-10-26 00:04:14| Waste Age
Residents are being asked to place materials at their curbside by 6 a.m. instead of 7 a.m. on Monday, October 31, 2016.
Tags: receive
early
safe
michigan
Toyota to start sales of fuel cell buses under the Toyota brand from early 2017
2016-10-21 16:55:25| Green Car Congress
Mercks KEYNOTE-045 Studying KEYTRUDA (pembrolizumab) in Advanced Bladder Cancer (Urothelial Cancer) Meets Primary Endpoint and Stops Early
2016-10-21 12:45:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KEYTRUDA is the First Immunotherapy to Show Improved Overall Survival Compared With Chemotherapy in Urothelial Cancer KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the phase 3 KEYNOTE-045 trial investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in patients with previously treated advanced urothelial cancer, met the primary endpoint of overall survival (OS). In this trial, KEYTRUDA was superior compared to investigator choice chemotherapy. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Courtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: advanced
early
primary
cancer
Sites : [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] next »